Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market

Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market

Launch of Novel Oral Therapies to Result in Major Market Changes

RELEASE DATE
20-Nov-2014
REGION
North America
Research Code: NED2-01-00-00-00
SKU: LS00131-NA-MR_16972
AvailableYesPDF Download

$3,950.00

Special Price $2,962.50 save 25 %

In stock
SKU
LS00131-NA-MR_16972

$3,950.00

$2,962.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study covers profiles of late-stage investigational products close to being launched, patent expiration timelines, products in clinical development, launched product profiles, and new product launch timelines.

Table of Contents

Key Findings

Key Findings (continued)

Companies to Watch

Defining Healthcare Trends in the Future

Executive Summary—CEO’s Perspective

Market Overview—Definitions

Market Overview—Definitions (continued)

Market Overview—Definitions (continued)

Market Overview—Definitions (continued)

Market Overview—Definitions (continued)

Market Overview—Definitions (continued)

Market Overview—Segmentation

Market Overview—Segmentation (continued)

Market Overview—Segmentation (continued)

Rheumatoid Arthritis Global Incidence

Competitive Factors and Assessment

Competitive Landscape—Count of Marketed and Pipeline Products

Competitive Landscape—Marketed and Pipeline Products

Marketed Product Analysis

Marketed Product Analysis (continued)

Patent Expiration Timeline

Pipeline Analysis—Products in Clinical Development

Pipeline Analysis—Products in Clinical Development (continued)

Pipeline Analysis—Products in Clinical Development (continued)

Product Launch Timeline

Phase 3 Clinical Program—Next Product Launches

Product Dashboard—Eli Lilly’s Baricitinib

Product Dashboard—Sanofi/Regeneron’s SAR153191/REGN88

Product Dashboard—Biocad’s BCD-020

The Last Word—Three Big Predictions

The Last Word—Discussion

Legal Disclaimer

Market Engineering Methodology

Table of Acronyms Used

Table of Acronyms Used (continued)

Table of Acronyms Used (continued)

Drivers Explained

Drivers Explained (continued)

Drivers Explained (continued)

Drivers Explained (continued)

Restraints Explained

Restraints Explained (continued)

Additional Sources of Information on Rheumatoid Arthritis

Additional Sources of Information on Rheumatoid Arthritis (continued)

Learn More—Next Steps

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study covers profiles of late-stage investigational products close to being launched, patent expiration timelines, products in clinical development, launched product profiles, and new product launch timelines.
More Information
No Index No
Podcast No
Author Lucila Rocca
WIP Number NED2-01-00-00-00
Is Prebook No